Franziska Szelinski, Dörner lab The CD19-Low/Negative B cell Axis and potential therapeutic implications in Systemic Lupus Erythematosus 3. Nov 2026, 09:15 Franziska Szelinski, Dörner lab
Oliver Knight, Romagnani lab Tissue-adapted NK cells shape pathogenic cDC1 niches in early arthritis 10. Nov 2026, 09:15 Oliver Knight, Romagnani lab
Ghislaine Blum, Strangfeld group External validity of JAK inhibitor trials and its influence on estimated treatment risks and effectiveness 17. Nov 2026, 09:15 Ghislaine Blum, Strangfeld group
